LACRIFRESH OCU-DRY 0.3% OSD
DeviceUse LACRIFRESH OCU-DRY 0.3% OSD as the daily contact lens lubricant product.
NCT Number: NCT07091825
This trial aims to evaluate the safety and effectiveness of LACRIFRESH OCU-DRY 0.3% OSD, a contact lens lubricant produced by AVIZOR, S.A. This clinical trial adopts a Multi-center, randomized, open-label, positive parallel-controlled design in accordance with the principles outlined in the Norms on the Quality Management for the Clinical Trials of Medical Devices issued by the National Medical Products Administration of China.
Meanwhile, following statistical requirements, 152 rigid contact lens wearers are planned to be enrolled after screening and meeting the inclusion criteria. Participants will be randomly assigned to groups and provided with lenses, lubricants, and care solutions accordingly. Clinical follow-up assessments are scheduled at 1 week, 1 month, and 3 months after use.
The primary efficacy indexes are the percentage of patients with binocular comfort score ≥ Level 3 at the 1-month follow-up and the percentage of patients with best corrected distance visual acuity with contact lenses for both eyes ≥5.0 at the 1-month follow-up after using the contact lens lubricant. Secondary efficacy indexes include, best corrected distance visual acuity with lenses, visual acuity with lenses, residual diopter, tear break-up time, uncorrected visual acuity, examination of contact lens fitting status, lens assessment, and contact lens lubricant evaluation during the corresponding follow-up periods. Safety indexes include slit lamp examination, fundus examination, IOP, corneal endothelial cell, adverse events, serious adverse events, device defects that may lead to serious adverse events, other device defects during the corresponding follow-up periods.
Interested in participating?
Request Info8 year and older
All sexes
Interventional
Not applicable
Beijing Aier Intech Eye Hospital, Beijing, Beijing Municipality, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use LACRIFRESH OCU-DRY 0.3% OSD as the daily contact lens lubricant product.
Use Rigid contact lens lubricant as the daily contact lens lubricant product.
Time frame: 1 month
Time frame: 1 month
Time frame: 1 week, 1 month, and 3 months
According to the Guidelines for Registration Review of Contact Lens Care Products of NMPA, subjective acceptability of contact lens care products is investigated through the investigation of subjective symptoms during follow-up, specifically including evaluations of comfort, visual and operability assessments. Higher scores indicate a more favorable outcome for the endpoint. For comfort assessment, the 6-point scale is defined as follows: Level 0: Painful; Level 1: Extremely uncomfortable; Level 2: Mildly uncomfortable; Level 3: Comfortable; Level 4: Very comfortable; Level 5: Excellent. For visual and operability assessments, the 6-point scale is defined as follows: Level 0: Unacceptable; Level 1: Very poor; Level 2: Poor; Level 3: Good; Level 4: Very good; Level 5: Outstanding.
Time frame: 1 week, and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 1 month and 3 months
Time frame: 1 week, 1 month, and 3 months
Time frame: 3 months
Time frame: From the date of randomization until the occurrence of adverse events, assessed for up to 3 months
Time frame: From the date of randomization until the occurrence of serious adverse event, assessed for up to 3 months
Contact information is provided by the study sponsor or research team.
Avizor SA
Industry
A Prospective, Multi-center, Open-Label, Randomized Controlled, Non-Inferiority Clinical Study Evaluating the Efficacy and Safety of Contact Lens Lubricant in Rigid Gas Permeable Corneal Contact Lens Wearers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07316998
Eye Diseases, Myopia
Paris, France
View Trial DetailsNCT07567040
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT07698977
Eye Diseases, Myopia
Budapest, Hungary
View Trial DetailsNCT07512102
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial Details